Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

9474	Companies
185433	Keywords
117775	Articles
99293	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 10/27/2025 at 22:15, 1 month 8 days ago

Onco-Innovations Announces Closing of Private Placement
Onco-Innovations Limited closes non-brokered private placement, issuing 1,428,570 units for gross proceeds of $2,000,000. Funds to be used for corporate purposes and cancer research. Statutory hold period applies to securities issued

Private Placement Securities Cancer Research Statutory Hold Period Onco-Innovations Limited
BRIEF

published on 10/15/2025 at 02:05, 1 month 21 days ago

Onco-Innovations annonce un placement privé de 2 millions de dollars

Placement Privé Mandats Approbation Réglementaire Onco-Innovations Christophe Gulka
BRIEF

published on 10/15/2025 at 02:05, 1 month 21 days ago

Onco-Innovations Announces $2 Million Private Placement

Private Placement Warrants Regulatory Approval Onco-Innovations Christopher Gulka
PRESS RELEASE

published on 10/15/2025 at 02:00, 1 month 21 days ago

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces non-brokered private placement of up to $2,000,000 and appointment of Mr. Christopher Gulka to the Board of Directors

Board Of Directors Private Placement Appointment Onco-Innovations Limited Christopher Gulka
BRIEF

published on 09/29/2025 at 06:05, 2 months 6 days ago

Onco-Innovations et Nucro-Technics lancent le programme préclinique PNKP

Etudes Précliniques Onco-Innovations Technologie PNKP Nucro-Techniques Développement Analytique
BRIEF

published on 09/29/2025 at 06:05, 2 months 6 days ago

Onco-Innovations and Nucro-Technics Initiate Preclinical PNKP Program

Preclinical Studies Onco-Innovations PNKP Technology Nucro-Technics Analytical Development
PRESS RELEASE

published on 09/29/2025 at 06:00, 2 months 6 days ago

Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
Onco-Innovations collaborates with Nucro-Technics for preclinical drug development services focusing on PNKP Technology. Nucro-Technics initiates lab work under IND enabling program with advanced analytical methods based on LC-MS

Preclinical Onco-Innovations PNKP Technology Nucro-Technics Analytical Methods
BRIEF

published on 09/22/2025 at 23:05, 2 months 12 days ago

Onco-Innovations Appoints Dr. Michael Lock to Advisory Board

Cancer Research Onco-Innovations PNKP Inhibitor Clinical Advisory Board Dr. Michael Lock
BRIEF

published on 09/22/2025 at 23:05, 2 months 12 days ago

Onco-Innovations nomme le Dr Michael Lock au conseil consultatif

Recherche Sur Le Cancer Onco-Innovations Inhibiteur De PNKP Dr Michael Lock Conseil Consultatif Clinique
PRESS RELEASE

published on 09/22/2025 at 23:00, 2 months 12 days ago

Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board
Onco-Innovations appoints Dr. Michael Lock, an expert in oncology and clinical trial design, to its Advisory Board. The company also grants RSUs to key personnel

Cancer Research RSUs Onco-Innovations Dr. Michael Lock Clinical Trial Design

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 59 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 4 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 34 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 29 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 34 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:15, 19 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 54 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 4 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 29 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 34 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 49 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 1 hour 49 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 1 hour 52 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 20 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 34 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE